Skip to content

AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair

Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair: A Prospective, Randomized Comparison to Evaluate the Incidence of Post-operative Pain Associated With Absorbable Fixation (AbsorbaTack) vs Conventional Fixation (ProTack) Following Laparoscopic Hernia Repair

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00749268
Enrollment
216
Registered
2008-09-09
Start date
2008-10-31
Completion date
2012-11-30
Last updated
2015-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia, Inguinal, Hernia, Ventral

Keywords

hernia

Brief summary

The objective of this study is to assess pain that occurs following hernia repair that is related to mesh fixation. The study is designed to see if there is any difference in pain after surgery between absorbable and permanent methods of mesh fixation in inguinal and ventral hernia repair.

Interventions

DEVICEAbsorbaTack

Comparison of different devices for mesh fixation. This intervention arm has absorbable tacks as the method of hernia mesh fixation. Application is during hernia repair and tacks will essentially absorb within the body after 1 year.

DEVICEProTack

Comparison of different devices for mesh fixation. This intervention is a permanent tack for hernia mesh fixation. Application is during hernia repair and the tacks will remain in the body.

Sponsors

Medtronic - MITG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ability and willingness to provide written informed consent and comply with the schedule of protocol assessments * Age \> 18 years * Subjects undergoing laparoscopic hernia repair with Parietex or Parietex Composite reinforcements depending on indication and fixation of reinforcements with helical tackers (ProTack, Covidien) or absorbable tacks (AbsorbaTack, Covidien) in accordance with recommendations for use

Exclusion criteria

* Pregnancy * Patients considered to have greater than reasonable surgical risk associated with general anesthesia and laparoscopic hernia repair * Known active infection or any major episode of infection requiring hospitalization or treatment with IV antibiotics or oral antibiotics within 30 days prior to screening * History of alcohol or drug abuse within 6 months prior to screening * History of chronic pain condition requiring more than 30 days of medical management * Use of an additional nonresorbable means of fixation (inguinal) * Patients considered not able to comply with the protocol and follow up schedule * ASA grade of 4 or above

Design outcomes

Primary

MeasureTime frameDescription
Postoperative PainDischarge, Month 1, Month 6, Month 12Pain Intensity Numeric Rating Scale (PI-NRS) - change from baseline. Treatments analyzed within inguinal arm and within ventral arm. Scale is 0 - 10 with 0 being no pain and 10 being worst pain imaginable.
Safety for Laparoscopic Hernia Repair as Measured by Number of Patients Experiencing Device Related EventsOne year

Secondary

MeasureTime frameDescription
Quality of LifePre-op, Month 1, Month 6, 1 yearQuality of life as measured by the SF-12 which is a multipurpose short form survey with 12 questions. The questions were combined, scored, and weighted to create a scale that provide glimpses into physical functioning and overall health-related-quality of life. The Physical Composite Score was computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.
Hernia RecurrenceDischarge, 1 Month, 6 Month, 1 year

Countries

United States

Participant flow

Recruitment details

Between November 4, 2008 and November 4, 2010, 117 subjects signed informed consent for the inguinal hernia arm of the study and 113 for the ventral arm. Of those subjects who consented, 106 and 110 were randomized to a treatment group (either AbsorbaTack™ or ProTack™) for inguinal and ventral hernia repair, respectively.

Participants by arm

ArmCount
Inguinal Arm - AbsorbaTack
Inguinal hernia study arm with AbsorbaTack as treatment.
52
Inguinal Arm - ProTack
Inguinal hernia study arm with ProTack as treatment.
52
Ventral Arm - Absorbatack
Ventral hernia study arm with AbsorbaTack as treatment.
56
Ventral Arm - ProTack
Ventral hernia study arm with ProTack as treatment.
54
Total214

Baseline characteristics

CharacteristicInguinal Arm - AbsorbaTackInguinal Arm - ProTackVentral Arm - AbsorbatackVentral Arm - ProTackTotal
Age, Continuous48.6 years
STANDARD_DEVIATION 15.5
53.3 years
STANDARD_DEVIATION 12.3
50.3 years
STANDARD_DEVIATION 11.3
53.8 years
STANDARD_DEVIATION 12.9
51.49 years
STANDARD_DEVIATION 13.15
Region of Enrollment
France
14 participants13 participants19 participants19 participants65 participants
Region of Enrollment
Germany
4 participants6 participants6 participants6 participants22 participants
Region of Enrollment
United States
34 participants33 participants31 participants29 participants127 participants
Sex: Female, Male
Female
1 Participants7 Participants20 Participants27 Participants55 Participants
Sex: Female, Male
Male
51 Participants45 Participants36 Participants27 Participants159 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
17 / 5320 / 5124 / 5533 / 54
serious
Total, serious adverse events
6 / 536 / 518 / 559 / 54

Outcome results

Primary

Postoperative Pain

Pain Intensity Numeric Rating Scale (PI-NRS) - change from baseline. Treatments analyzed within inguinal arm and within ventral arm. Scale is 0 - 10 with 0 being no pain and 10 being worst pain imaginable.

Time frame: Discharge, Month 1, Month 6, Month 12

Population: 1 patient in the Ventral Arm - AbsorbaTack had only pre-operative pain scores available so was unable to be included in this analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Inguinal Arm - AbsorbaTackPostoperative PainChange from baseline - discharge.8 units on a scaleStandard Deviation 2.8
Inguinal Arm - AbsorbaTackPostoperative PainChange from baseline - 1 month-1.1 units on a scaleStandard Deviation 2.7
Inguinal Arm - AbsorbaTackPostoperative PainChange from baseline - 6 months-1.8 units on a scaleStandard Deviation 2.4
Inguinal Arm - AbsorbaTackPostoperative PainChange from baseline - 1 year-1.2 units on a scaleStandard Deviation 2.3
Inguinal Arm - ProTackPostoperative PainChange from baseline - 1 month-.4 units on a scaleStandard Deviation 1.8
Inguinal Arm - ProTackPostoperative PainChange from baseline - 6 months-.6 units on a scaleStandard Deviation 1.8
Inguinal Arm - ProTackPostoperative PainChange from baseline - 1 year-.9 units on a scaleStandard Deviation 1.6
Inguinal Arm - ProTackPostoperative PainChange from baseline - discharge2.0 units on a scaleStandard Deviation 2.2
Ventral Arm - AbsorbatackPostoperative PainChange from baseline - 6 months-1.3 units on a scaleStandard Deviation 2.8
Ventral Arm - AbsorbatackPostoperative PainChange from baseline - 1 month-.7 units on a scaleStandard Deviation 3
Ventral Arm - AbsorbatackPostoperative PainChange from baseline - 1 year-1.8 units on a scaleStandard Deviation 2.7
Ventral Arm - AbsorbatackPostoperative PainChange from baseline - discharge2.2 units on a scaleStandard Deviation 3.8
Ventral Arm - ProTackPostoperative PainChange from baseline - 1 year-.8 units on a scaleStandard Deviation 1.8
Ventral Arm - ProTackPostoperative PainChange from baseline - 1 month.5 units on a scaleStandard Deviation 1.9
Ventral Arm - ProTackPostoperative PainChange from baseline - discharge3.3 units on a scaleStandard Deviation 3.6
Ventral Arm - ProTackPostoperative PainChange from baseline - 6 months-.6 units on a scaleStandard Deviation 1.7
Primary

Safety for Laparoscopic Hernia Repair as Measured by Number of Patients Experiencing Device Related Events

Time frame: One year

ArmMeasureValue (NUMBER)
Inguinal Arm - AbsorbaTackSafety for Laparoscopic Hernia Repair as Measured by Number of Patients Experiencing Device Related Events7 participants
Inguinal Arm - ProTackSafety for Laparoscopic Hernia Repair as Measured by Number of Patients Experiencing Device Related Events8 participants
Ventral Arm - AbsorbatackSafety for Laparoscopic Hernia Repair as Measured by Number of Patients Experiencing Device Related Events7 participants
Ventral Arm - ProTackSafety for Laparoscopic Hernia Repair as Measured by Number of Patients Experiencing Device Related Events8 participants
Secondary

Hernia Recurrence

Time frame: Discharge, 1 Month, 6 Month, 1 year

ArmMeasureGroupValue (NUMBER)
Inguinal Arm - AbsorbaTackHernia Recurrence6 Month2 participants
Inguinal Arm - AbsorbaTackHernia RecurrenceDischarge0 participants
Inguinal Arm - AbsorbaTackHernia Recurrence1 Year0 participants
Inguinal Arm - AbsorbaTackHernia Recurrence1 Month0 participants
Inguinal Arm - ProTackHernia RecurrenceDischarge1 participants
Inguinal Arm - ProTackHernia Recurrence6 Month1 participants
Inguinal Arm - ProTackHernia Recurrence1 Month1 participants
Inguinal Arm - ProTackHernia Recurrence1 Year1 participants
Ventral Arm - AbsorbatackHernia Recurrence1 Month1 participants
Ventral Arm - AbsorbatackHernia RecurrenceDischarge0 participants
Ventral Arm - AbsorbatackHernia Recurrence6 Month3 participants
Ventral Arm - AbsorbatackHernia Recurrence1 Year1 participants
Ventral Arm - ProTackHernia RecurrenceDischarge0 participants
Ventral Arm - ProTackHernia Recurrence1 Month2 participants
Ventral Arm - ProTackHernia Recurrence1 Year0 participants
Ventral Arm - ProTackHernia Recurrence6 Month0 participants
Secondary

Quality of Life

Quality of life as measured by the SF-12 which is a multipurpose short form survey with 12 questions. The questions were combined, scored, and weighted to create a scale that provide glimpses into physical functioning and overall health-related-quality of life. The Physical Composite Score was computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

Time frame: Pre-op, Month 1, Month 6, 1 year

Population: Participant # above reflects those at pre-op. Arms ended study with 34, 39, 36 and 39 subjects, respectively.

ArmMeasureGroupValue (MEAN)Dispersion
Inguinal Arm - AbsorbaTackQuality of Life1 year55.8 units on a scaleStandard Deviation 7.4
Inguinal Arm - AbsorbaTackQuality of LifePre-Op48.8 units on a scaleStandard Deviation 8.6
Inguinal Arm - AbsorbaTackQuality of Life1 Month49.1 units on a scaleStandard Deviation 7.9
Inguinal Arm - AbsorbaTackQuality of Life6 Month55.3 units on a scaleStandard Deviation 6.6
Inguinal Arm - ProTackQuality of Life6 Month54.4 units on a scaleStandard Deviation 6.3
Inguinal Arm - ProTackQuality of Life1 year53.8 units on a scaleStandard Deviation 6
Inguinal Arm - ProTackQuality of LifePre-Op50.6 units on a scaleStandard Deviation 8.1
Inguinal Arm - ProTackQuality of Life1 Month50.2 units on a scaleStandard Deviation 7
Ventral Arm - AbsorbatackQuality of Life6 Month51.6 units on a scaleStandard Deviation 9.4
Ventral Arm - AbsorbatackQuality of Life1 year52.0 units on a scaleStandard Deviation 8.1
Ventral Arm - AbsorbatackQuality of Life1 Month45.4 units on a scaleStandard Deviation 9.5
Ventral Arm - AbsorbatackQuality of LifePre-Op46.1 units on a scaleStandard Deviation 9.3
Ventral Arm - ProTackQuality of Life1 year53.3 units on a scaleStandard Deviation 6.6
Ventral Arm - ProTackQuality of Life6 Month51.1 units on a scaleStandard Deviation 7.6
Ventral Arm - ProTackQuality of LifePre-Op49.0 units on a scaleStandard Deviation 9.1
Ventral Arm - ProTackQuality of Life1 Month45.2 units on a scaleStandard Deviation 9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026